Geri
Cellbxhealth PLC (ANPCF) Fiyatı
ANPCF Hisse Senedi Fiyat Grafiği
ANPCF Kazanmak
Cellbxhealth PLC
$0.01
0%
$0
Kapanışta: Jan 16, 16:00:00 GMT-5
$0.01
0%
$0
Sonrası Piyasa: Jan 16, 20:00:00 GMT-5
Son Finansal Sonuçlar: Q4 '22
Raporlandı: 2023-04-21
Geçmiş Kazançlar
Dönemlik
Yıllık
EPS
Gelir
Earnings FAQ
ANPCF'ün son EPS'si beklentilerle karşılaştırıldığında nasıldı?
Cellbxhealth PLC ANPCF'ün son çeyrekteki geliri nasıl performans gösterdi?
Cellbxhealth PLC'in gelir tahmini nedir?
Cellbxhealth PLC'in kazanç kalite puanı nedir?
Cellbxhealth PLC kazançlarını ne zaman rapor eder?
Cellbxhealth PLC'in beklenen kazançları nelerdir?
Cellbxhealth PLC kazanç beklentilerini aştı mı?
Önemli İstatistikler
Önceki Kapanış
$0.0168
Açılış fiyatı
$0.0168
Günün Aralığı
$0.0168 - $0.025
52 haftalık aralık
$0.0146 - $0.161
İşlem hacmi
10.0K
Ort.Hacim
3.2K
EPS (TTM)
-0.06
Dividend yield
--
Piyasa Değeri
$32.7M
ANPCF nedir?
ANGLE Plc is a holding company, which engages in the provision of its subsidiaries engages in providing products in cancer diagnostics and foetal health. The company is headquartered in Guildford, Surrey and currently employs 119 full-time employees. The company went IPO on 2004-03-17. The product portfolio comprises the Parsortix platform with associated consumables and assays. Its Parsortix platform harvests CTCs from blood and enables comprehensive downstream analysis - including whole-cell imaging, proteomic profiling and full genomic workflows - supporting research, drug development and clinical oncology. Its Parsortix PC1 system is the first FDA cleared medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for subsequent, user-validated analysis.Its Parsortix PR1 System is a semi-automated platform for epitope-independent CTC isolation, used in research and clinical trials for multiple cancer types.
Özellikler
Ticaret Stratejileri
Kaynaklar
© 2025 Finture Development Limited. All rights reserved